Literature DB >> 1137378

Purification of two Clostridium bacteriocins by procedures appropriate to hydrophobic proteins.

D J Clarke, R M Robson, J G Morris.   

Abstract

Two clostridocins distinguishable by their different modes of action on Clostridium pasteurianum have been isolated, namely, butyricin 7423 found in cultures of Clostridium butyricum NCIB 7423 and perfringocin 11105 produced by Clostridium perfringens type A, NCIB 11105. Both were trypsin-susceptible proteins which were soluble in concentrated aqueous ethanol and were able to bind large amounts of the nonionic detergent Triton X-100. In the presence of Triton X-100, butyricin 7423 behaved as a hydrophobic protein in being concentrated in the polyethylene glycol layer of a three-phase partition system of dextran-Ficoll-polyethylene glycol. Their capacity to bind Triton X-100 was exploited in a purification procedure applicable to both bacteriocins. After aqueous ethanol extraction of an ammonium sulfate-precipitated fraction (and, in the case of the perfringocin, a heat-treatment step), a bacteriocin-Triton X-100 adduct was purified by gel filtration through Sepharose 6B. The bacteriocin was then freed of Triton X-100 by chromatography on Sephadex LH-20. Samples of butyricin 7423 purified in this way from different sources contained variable amounts of carbohydrate. Yet sodium dodecyl sulfate-gel electrophoresis revealed the existence of a polypeptide component of 32,500 daltons (+/-10%), which displayed the biological activity of butyricin 7423 in the absence of any detectable associated carbohydrate (or lipid). Preparations of perfringocin 11105 contained no carbohydrate or lipid and migrated in sodium dodecyl sulfate-gel electrophoresis as a single protein component of 76,000 daltons (+/-10%). It was concluded that both bacteriocins behave as amphiphilic proteins, and some implications of this finding are considered.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1137378      PMCID: PMC429121          DOI: 10.1128/AAC.7.3.256

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Production of colicine by single bacteria.

Authors:  H OZEKI; B A STOCKER; H DE MARGERIE
Journal:  Nature       Date:  1959-08-01       Impact factor: 49.962

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Application of the phase partition method to a hydrophobic membrane protein, phospholipase A1 from Escherichia coli.

Authors:  P A Albertsson
Journal:  Biochemistry       Date:  1973-06-19       Impact factor: 3.162

5.  Purification and properties of boticin P produced by Clostridium botulinum.

Authors:  A H Lau; R Z Hawirko; C T Chow
Journal:  Can J Microbiol       Date:  1974-03       Impact factor: 2.419

6.  Bacteriocins of Clostridium perfringens. 2. Studies on mode of action.

Authors:  D E Mahony; M E Butler; R G Lewis
Journal:  Can J Microbiol       Date:  1971-11       Impact factor: 2.419

7.  The binding of detergents to lipophilic and hydrophilic proteins.

Authors:  A Helenius; K Simons
Journal:  J Biol Chem       Date:  1972-06-10       Impact factor: 5.157

8.  Hydrophobic free energy, micelle formation and the association of proteins with amphiphiles.

Authors:  C Tanford
Journal:  J Mol Biol       Date:  1972-06-14       Impact factor: 5.469

9.  ISOLATION AND CHARACTERIZATION OF BACTERIOPHAGES ACTIVE ON CLOSTRIDIUM SPOROGENES.

Authors:  J V BETZ; K E ANDERSON
Journal:  J Bacteriol       Date:  1964-02       Impact factor: 3.490

10.  Purification and some properties of two boticins.

Authors:  J S Ellison; J A Kautter
Journal:  J Bacteriol       Date:  1970-10       Impact factor: 3.490

View more
  11 in total

1.  Comparative study of ten bacteriocins of Clostridium perfringens.

Authors:  D E Mahony; A Li
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

2.  Inhibition of Clostridium botulinum by strains of Clostridium perfringens isolated from soil.

Authors:  L D Smith
Journal:  Appl Microbiol       Date:  1975-08

3.  Induction of bacteriocins from Clostridium perfringens by treatment with mitomycin C.

Authors:  D E Mahony
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

4.  Streptococcin A-FF22: nisin-like antibiotic substance produced by a group A streptococcus.

Authors:  J R Tagg; L W Wannamaker
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

Review 5.  Bacteriocins of gram-positive bacteria.

Authors:  J R Tagg; A S Dajani; L W Wannamaker
Journal:  Bacteriol Rev       Date:  1976-09

6.  The mother-cell-membrane adenosine triphosphatase of sporulating Clostridium pasteurianum.

Authors:  D J Clarke; J G Morris
Journal:  Biochem J       Date:  1980-01-15       Impact factor: 3.857

7.  Butyricin 7423 and the membrane H+ -ATPase of Clostridium pasteurianum.

Authors:  D J Clarke; D B Kell; C D Morley; J G Morris
Journal:  Arch Microbiol       Date:  1982-02       Impact factor: 2.552

8.  Production, purification, and preliminary characterization of a gonococcal growth inhibitor produced by a coagulase-negative staphylococcus isolated from the urogenital flora.

Authors:  R Beaudet; J G Bisaillon; S A Saheb; M Sylvestre
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

Review 9.  Molecular genetics and pathogenesis of Clostridium perfringens.

Authors:  J I Rood; S T Cole
Journal:  Microbiol Rev       Date:  1991-12

10.  Partial purification of a dicyclohexylcarbodi-imide-sensitive membrane adenosine triphosphatase complex from the obligately anaerobic bacterium Clostridium Pasteurianum.

Authors:  D J Clarke; J G Morris
Journal:  Biochem J       Date:  1976-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.